Dematiaceous Fungi

 

 Buy Article Permissions and Reprints

Dematiaceous fungi are the etiologic agents of phaeohyphomycosis and are increasingly recognized as causing disease in humans. A wide variety of infectious syndromes are seen, from local infections due to trauma to widely disseminated infection in immunocompromised patients. Pulmonary disease may be divided into allergic bronchopulmonary and nonallergic syndromes, depending on the species. These fungi have unique pathogenic mechanisms owing to the presence of melanin in their cell walls, which imparts the characteristic dark color to their spores and hyphae. Melanin is a known virulence factor in certain fungi, including Cryptococcus neoformans and Wangiella dermatitidis. Therapy depends upon the clinical syndrome. Local infection may be cured with excision alone, whereas systemic disease is often refractory to therapy. Azoles such as itraconazole and voriconazole have the most consistent in vitro activity, though there is more clinical experience with itraconazole. Further studies are needed to better understand the pathogenesis and treatment of these uncommon infections.

REFERENCES

• 1 McGinnis M R. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology.  J Am Acad Dermatol. 1983;  8 1-16
  PubMedGoogle Scholar
• 2 Rinaldi M G. Phaeohyphomycosis.  Dermatol Clin. 1996;  14 147-153
  PubMedGoogle Scholar
• 3 Matsumoto T, Ajello L, Matsuda T, Szaniszlo P J, Walsh T J. Developments in hyalohyphomycosis and phaeohyphomycosis.  J Med Vet Mycol. 1994;  32(suppl 1) 329-349
  PubMedGoogle Scholar
• 4 Padhye A A, Bennett J E, McGinnis M R, Sigler L, Fliss A, Salkin I F. Biosafety considerations in handling medically important fungi.  Med Mycol. 1998;  36(suppl 1) 258-265
  PubMedGoogle Scholar
• 5 McGinnis M R, Pasarell L. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.  J Clin Microbiol. 1998;  36 2353-2355
  PubMedGoogle Scholar
• 6 Acland K M, Hay R J, Groves R. Cutaneous infection with Alternaria alternata complicating immunosuppression: successful treatment with itraconazole.  Br J Dermatol. 1998;  138 354-356
  CrossrefPubMedGoogle Scholar
• 7 Agarwal A, Singh S M. A case of cutaneous phaeohyphomycosis caused by Exserohilum rostratum, its in vitro sensitivity and review of literature.  Mycopathologia. 1995;  131 9-12
  CrossrefPubMedGoogle Scholar
• 8 Allred B J. Subcutaneous phaeohyphomycosis due to Exophiala jeanselmei in an immunosuppressed patient: case report.  N Z Med J. 1990;  103 321-322
  PubMedGoogle Scholar
• 9 Burges G E, Walls C T, Maize J C. Subcutaneous phaeohyphomycosis caused by Exserohilum rostratum in an immunocompetent host.  Arch Dermatol. 1987;  123 1346-1350
  CrossrefPubMedGoogle Scholar
• 10 Chuan M T, Wu M C. Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei: successful treatment with itraconazole.  Int J Dermatol. 1995;  34 563-566
  PubMedGoogle Scholar
• 11 Fincher R M, Fisher J F, Padhye A A, Ajello L, Steele Jr J C. Subcutaneous phaeohyphomycotic abscess caused by Phialophora parasitica in a renal allograft recipient.  J Med Vet Mycol. 1988;  26 311-314
  PubMedGoogle Scholar
• 12 Campos-Takaki G M, Jardim M L. Report of chronic subcutaneous abscesses caused by Exophiala spinifera .  Mycopathologia. 1994;  127 73-76
  CrossrefPubMedGoogle Scholar
• 13 Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao G N. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India.  Cornea. 2002;  21 555-559
  CrossrefPubMedGoogle Scholar
• 14 Sundaram B M, Badrinath S, Subramanian S. Studies on mycotic keratitis.  Mycoses. 1989;  32 568-572
  PubMedGoogle Scholar
• 15 Garg P, Gopinathan U, Choudhary K, Rao G N. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi.  Ophthalmology. 2000;  107 574-580
  CrossrefPubMedGoogle Scholar
• 16 Ferguson B J. Definitions of fungal rhinosinusitis.  Otolaryngol Clin North Am. 2000;  33 227-235
  CrossrefPubMedGoogle Scholar
• 17 Houser S M, Corey J P. Allergic fungal rhinosinusitis: pathophysiology, epidemiology, and diagnosis.  Otolaryngol Clin North Am. 2000;  33 399-409
  CrossrefPubMedGoogle Scholar
• 18 Kuhn F A, Javer A R. Allergic fungal rhinosinusitis: perioperative management, prevention of recurrence, and role of steroids and antifungal agents.  Otolaryngol Clin North Am. 2000;  33 419-433
  CrossrefPubMedGoogle Scholar
• 19 Greenberger P A. Allergic bronchopulmonary aspergillosis.  J Allergy Clin Immunol. 2002;  110 685-692
  CrossrefPubMedGoogle Scholar
• 20 Venarske D L, deShazo R D. Sinobronchial allergic mycosis: the SAM syndrome.  Chest. 2002;  121 1670-1676
  CrossrefPubMedGoogle Scholar
• 21 Halwig J M, Brueske D A, Greenberger P A, Dreisin R B, Sommers H M. Allergic bronchopulmonary curvulariosis.  Am Rev Respir Dis. 1985;  132 186-188
  PubMedGoogle Scholar
• 22 Saenz R E, Brown W D, Sanders C V. Allergic bronchopulmonary disease caused by Bipolaris hawaiiensis presenting as a necrotizing pneumonia: case report and review of literature.  Am J Med Sci. 2001;  321 209-212
  PubMedGoogle Scholar
• 23 Lake F R, Froudist J H, McAleer R, Gillon R L, Tribe A E, Thompson P J. Allergic bronchopulmonary fungal disease caused by Bipolaris and Curvularia .  Aust N Z J Med. 1991;  21 871-874
  PubMedGoogle Scholar
• 24 Travis W D, Kwon-Chung K J, Kleiner D E et al.. Unusual aspects of allergic bronchopulmonary fungal disease: report of two cases due to Curvularia organisms associated with allergic fungal sinusitis.  Hum Pathol. 1991;  22 1240-1248
  CrossrefPubMedGoogle Scholar
• 25 McAleer R, Kroenert D B, Elder J L, Froudist J H. Allergic bronchopulmonary disease caused by Curvularia lunata and Drechslera hawaiiensis .  Thorax. 1981;  36 338-344
  PubMedGoogle Scholar
• 26 Mroueh S, Spock A. Allergic bronchopulmonary disease caused by Curvularia in a child.  Pediatr Pulmonol. 1992;  12 123-126
  PubMedGoogle Scholar
• 27 Adam R D, Paquin M L, Petersen E A et al.. Phaeohyphomycosis caused by the fungal genera Bipolaris and Exserohilum: a report of 9 cases and review of the literature.  Medicine (Baltimore). 1986;  65 203-217
  PubMedGoogle Scholar
• 28 Wark P AB, Gibson P G. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment.  Respirology. 2001;  6 1-7
  CrossrefPubMedGoogle Scholar
• 29 Odell J A, Alvarez S, Cvitkovich D G, Cortese D A, McComb B L. Multiple lung abscesses due to Ochroconis gallopavum, a dematiaceous fungus, in a nonimmunocompromised wood pulp worker.  Chest. 2000;  118 1503-1505
  CrossrefPubMedGoogle Scholar
• 30 Barenfanger J, Ramirez F, Tewari R P, Eagleton L. Pulmonary phaeohyphomycosis in a patient with hemoptysis.  Chest. 1989;  95 1158-1160
  CrossrefPubMedGoogle Scholar
• 31 Mazur J E, Judson M A. A case report of a Dactylaria fungal infection in a lung transplant patient.  Chest. 2001;  119 651-653
  CrossrefPubMedGoogle Scholar
• 32 Burns K E, Ohori N P, Iacono A T. Dactylaria gallopava infection presenting as a pulmonary nodule in a single-lung transplant recipient.  J Heart Lung Transplant. 2000;  19 900-902
  PubMedGoogle Scholar
• 33 Jenney A, Maslen M, Bergin P, Tang S K, Esmore D, Fuller A. Pulmonary infection due to Ochroconis gallopavum treated successfully after orthotopic heart transplantation.  Clin Infect Dis. 1998;  26 236-237
  PubMedGoogle Scholar
• 34 Tamm M, Malouf M, Glanville A. Pulmonary Scedosporium infection following lung transplantation.  Transpl Infect Dis. 2001;  3 189-194
  CrossrefPubMedGoogle Scholar
• 35 Greig J R, Khan M A, Hopkinson N S, Marshall B G, Wilson P O, Rahman S U. Pulmonary infection with Scedosporium prolificans in an immunocompetent individual.  J Infect. 2001;  43 15-17
  CrossrefPubMedGoogle Scholar
• 36 Samuels T, Morava-Protzner I, Youngson B, Huang S N. Calcification in bronchopulmonary sequestration.  Can Assoc Radiol J. 1989;  40 106-107
  PubMedGoogle Scholar
• 37 Manian F A, Brischetto M J. Pulmonary infection due to Exophiala jeanselmei: successful treatment with ketoconazole.  Clin Infect Dis. 1993;  16 445-446
  PubMedGoogle Scholar
• 38 Borges Jr M C, Warren S, White W, Pellettiere E V. Pulmonary phaeohyphomycosis due to Xylohypha bantiana .  Arch Pathol Lab Med. 1991;  115 627-629
  PubMedGoogle Scholar
• 39 Owili D M, Nsanzumuhire H, Ngare W. Chromoblastomycosis caused by Cladosporium trichoides and associated pulmonary involvement and case report.  East Afr Med J. 1982;  59 230-234
  PubMedGoogle Scholar
• 40 Brenner S A, Morgan J, Rickert P D, Rimland D. Cladophialophora bantiana isolated from an AIDS patient with pulmonary infiltrates.  J Med Vet Mycol. 1996;  34 427-429
  PubMedGoogle Scholar
• 41 Yeghen T, Fenelon L, Campbell C K et al.. Chaetomium pneumonia in patient with acute myeloid leukaemia.  J Clin Pathol. 1996;  49 184-186
  PubMedGoogle Scholar
• 42 Hoppin E C, McCoy E L, Rinaldi M G. Opportunistic mycotic infection caused by Chaetomium in a patient with acute leukemia.  Cancer. 1983;  52 555-556
  PubMedGoogle Scholar
• 43 Brubaker L H, Steele Jr J C, Rissing J P. Cure of Curvularia pneumonia by amphotericin B in a patient with megakaryocytic leukemia.  Arch Pathol Lab Med. 1988;  112 1178-1179
  PubMedGoogle Scholar
• 44 Lundstrom T S, Fairfax M R, Dugan M C et al.. Phialophora verrucosa infection in a BMT patient.  Bone Marrow Transplant. 1997;  20 789-791
  CrossrefPubMedGoogle Scholar
• 45 Tan H P, Wahlstrom H E, Zamora J U, Hassanein T. Aureobasidium pneumonia in a post liver transplant recipient: a case report.  Hepatogastroenterology. 1997;  44 1215-1218
  PubMedGoogle Scholar
• 46 Diemert D, Kunimoto D, Sand C, Rennie R. Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.  Scand J Infect Dis. 2001;  33 777-779
  CrossrefPubMedGoogle Scholar
• 47 Malani P N, Bleicher J J, Kauffman C A, Davenport D S. Disseminated Dactylaria constricta infection in a renal transplant recipient.  Transpl Infect Dis. 2001;  3 40-43
  PubMedGoogle Scholar
• 48 Revankar S G, Sutton D A, Rinaldi M G. Primary central nervous system phaeohyphomycosis: a review of 101 cases.  Clin Infect Dis. 2004;  38 206-216
  CrossrefPubMedGoogle Scholar
• 49 Revankar S G, Patterson J E, Sutton D A, Pullen R, Rinaldi M G. Disseminated phaeohyphomycosis: review of an emerging mycosis.  Clin Infect Dis. 2002;  34 467-476
  CrossrefPubMedGoogle Scholar
• 50 Meletiadis J, Mouton J W, Rodriguez-Tudela J L, Meis J FGM, Verweij P E. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans .  Antimicrob Agents Chemother. 2000;  44 470-472
  CrossrefPubMedGoogle Scholar
• 51 Howden B P, Slavin M A, Schwarer A P, Mijch A M. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.  Eur J Clin Microbiol Infect Dis. 2003;  22 111-113
  PubMedGoogle Scholar
• 52 Jacobson E S. Pathogenic roles for fungal melanins.  Clin Microbiol Rev. 2000;  13 708-717
  CrossrefPubMedGoogle Scholar
• 53 Butler M J, Day A W. Fungal melanins: a review.  Can J Microbiol. 1998;  44 1115-1136
  CrossrefPubMedGoogle Scholar
• 54 Hamilton A J, Gomez B L. Melanins in fungal pathogens.  J Med Microbiol. 2002;  51 189-191
  CrossrefPubMedGoogle Scholar
• 55 Dixon D M, Polak A, Szaniszlo P J. Pathogenicity and virulence of wild-type and melanin-deficient Wangiella dermatitidis .  J Med Vet Mycol. 1987;  25 97-106
  PubMedGoogle Scholar
• 56 Kwon-Chung K J, Polacheck I, Popkin T J. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice.  J Bacteriol. 1982;  150 1414-1421
  PubMedGoogle Scholar

Sanjay G RevankarM.D. 

Dallas VA Medical Center, Division of Infectious Diseases (111D)

4500 S. Lancaster Rd.

Dallas, TX 75216

Email: sanjay.revankar@med.va.gov